Biomarker services

OHMX.bio offers a full range of biomarker discovery and development services, designed to meet the needs of biopharma, biotechnology, and clinical research clients at every stage of their projects. Whether your goal is early-stage discovery, translational research, or clinical validation, OHMX.bio provides cutting-edge technologies and expert guidance to help you identify, validate, and implement meaningful biomarkers.

Biomarker service categories

OHMX.bio’s biomarker solutions are divided into five main categories, each tailored to specific stages of biomarker development and types of research. Click on any category to explore more detailed information about each offering:

Discovery and Non-Clinical Biomarkers

Designed for early-stage biomarker identification and preclinical research, this service focuses on identifying potential biomarkers for drug response, toxicity, and efficacy. These solutions are ideal for exploratory studies and hypothesis generation, leveraging high-throughput sequencing and qPCR technologies to identify new candidates with precision and accuracy.

Clinical Biomarkers

For clinical trials and late-stage development, OHMX.bio offers validated biomarker assays to ensure regulatory compliance and data reproducibility. These solutions are critical for patient stratification, safety monitoring, and therapeutic response assessments in clinical settings. OHMX.bio’s sequencing capabilities provide a broad overview of genetic biomarkers, ideal for identifying and monitoring key mutations and expression changes in clinical phases.

MRD (Minimal Residual Disease) Testing

OHMX.bio provides advanced MRD testing using both mass spectrometry and sequencing technologies. MRD testing is critical for detecting low levels of residual disease in samples such as blood, bone marrow, and tissue biopsies. OHMX.bio’s sensitive detection methods can identify minute levels of disease, supporting oncology and hematology research. With expertise in both genomic and proteomic MRD detection, OHMX.bio ensures accurate, high-sensitivity results.

NGS-Based Biomarkers

Utilizing next-generation sequencing (NGS), OHMX.bio offers services for genomic, transcriptomic, and epigenomic biomarker discovery and validation. This approach is ideal for genomic profiling, mutation detection, gene expression studies, and RNA modifications, providing high sensitivity and specificity for biomarker identification. Sequencing is a core expertise at OHMX.bio, making this service a cornerstone for genetic biomarker discovery and profiling.

Proteomics-Based Biomarkers

OHMX.bio offers comprehensive proteomics services, including mass spectrometry-based and sequencing-based targeted proteomics approaches. These services are ideal for the discovery and quantification of protein and metabolite biomarkers and can target post-translational modifications or other key changes. OHMX.bio also offers qPCR-based and sequencing-based targeted proteomics for focused biomarker validation. ELISA and flow cytometry are also available to provide high-specificity protein detection.

Each of these services is supported by our cutting-edge bioinformatics team, ensuring that your data is accurately processed, analyzed, and interpreted.

90+

Satisfied customers trusted us with their samples

190+

Solutions offered to progress research and clinical trials

22.300+ km

Of nucleotides sequenced end-to-end. That’s the earth’s diameter, twice!

Choosing the right biomarker service

Selecting the appropriate biomarker solution depends on your research stage and objectives:

OHMX.bio’s team of experts can help guide you to the appropriate service for your needs, ensuring that your biomarker strategy is optimized for success.

What are biomarkers?

Biomarkers are measurable indicators of a biological state or condition, playing a critical role in understanding disease mechanisms, predicting treatment responses, and monitoring therapeutic outcomes. They can range from genetic mutations and RNA transcripts to proteins and metabolites. At OHMX.bio, we specialize in identifying and validating biomarkers across a wide range of technologies, from sequencing to proteomics, supporting both discovery and clinical translation.

Why choose OHMX.bio for biomarker services?

At OHMX.bio, we go beyond data generation to deliver actionable insights. Here’s why researchers and clinicians trust us.

Thanks to the services of Ohmx.bio, we were able to generate super high quality Ribo-seq data, which we would not have been able to generate ourselves.

We were very well assisted and helped by the expert team of OHMX in our sequencing projects. Definitely when things get challenging (advanced sequencing protocols, low input quantities), the team thrives.

OHMX.bio’s emphasis on data quality control and validation in transcriptomics analysis has earned our trust in their services. Their flexible project approach accommodates additional ad hoc requirements for sequencing and data delivery.

I am very happy with the collaboration with OHMX.bio. They delivered within the agreed timeline, and we got more than we bargained for. The results were well documented, and the study report was directly translatable to the patients and the product we were testing.

Our collaboration with OHMX has been exceptional; their professionalism and efficiency exceeded our expectations. Their knowledgeable team provided timely answers, ensuring seamless communication throughout the project.

Partner with OHMX.bio for biomarker innovation

OHMX.bio’s biomarker services are designed to empower your research and accelerate development timelines. Explore our discovery, NGS-based, proteomics-based, and clinical biomarker services to find the right solution for your project. Contact OHMX.bio today to learn how we can support your biomarker strategy.

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!

TESTING SERVICES

TECHNOLOGIES

EXPERTISE

QUALITY